Teglarinad chloride
Term · Oncology and biomedicine · MLC-T-ONC-017044
A water-soluble prodrug of a cyanoguanidine compound with potential antineoplastic activity. In vivo, teglarinad chloride is rapidly converted into active drug through hydrolytic cleavage of a carbonate ester bond. Although the exact mechanism of action has yet to be fully elucidated, the active drug appears to antagonize nuclear factor-kappa B (NF-kB) transcription, resulting in the induction of tumor cell apoptosis.
| Identifier | MLC-T-ONC-017044 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | apoptosis inducer GMX1777 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017044",
"term": "Teglarinad chloride",
"field": "Oncology and biomedicine",
"definition": "A water-soluble prodrug of a cyanoguanidine compound with potential antineoplastic activity. In vivo, teglarinad chloride is rapidly converted into active drug through hydrolytic cleavage of a carbonate ester bond. Although the exact mechanism of action has yet to be fully elucidated, the active drug appears to antagonize nuclear factor-kappa B (NF-kB) transcription, resulting in the induction of tumor cell apoptosis.",
"synonyms": [
"apoptosis inducer GMX1777"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/teglarinad-chloride/"
}
Record 16,105 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.